Skip to main content

Investor FAQs

What does Puma Biotechnology do? When was Puma founded and where was it incorporated? When did Puma become a public company? On which exchange is Puma’s stock traded and what is the stock symbol? How many shares of Puma Biotechnology common stock are outstanding? What is Puma’s CUSIP number? Does Puma pay dividends on its common stock? Does Puma offer a Direct Stock Purchase Plan? Who serves as Puma’s stock transfer agent? If I’ve lost my stock certificate or have a change of address, whom should I contact? Who is Puma’s independent registered public accounting firm? When does Puma’s fiscal year end? When and where will Puma’s annual meeting of stockholders be held? Where are Puma’s headquarters located? How can I get copies of Puma’s financial statements or other regulatory filings? If I have questions regarding the company, whom should I contact?
What does Puma Biotechnology do?

Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. We in-licensing the global development and commercialization rights to three drug candidates -- PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357.

back to top
When was Puma founded and where was it incorporated?

Puma was founded in September 2010 as a private company and incorporated in Delaware.

back to top
When did Puma become a public company?

On October 4, 2011, Puma completed a reverse merger with Innovative Acquisitions Corp., a publicly reporting “shell” company with no specific business plan or purpose. As a result of the merger, Puma became a wholly owned subsidiary of Innovative Acquisitions. The merged company changed its name to Puma Biotechnology and adopted Puma’s business plan. The company’s common stock began trading on April 20, 2012.

back to top
On which exchange is Puma’s stock traded and what is the stock symbol?

Puma Biotechnology moved its common stock listing to the Nasdaq Stock Market on January 3, 2017, and trades under the symbol "PBYI." From October 19, 2012, through December 30, 2016, PBYI was listed on the New York Stock Exchange. Previously, PBYI was quoted on the OTC Bulletin Board and OTCQB Market.

back to top
How many shares of Puma Biotechnology common stock are outstanding?

As of April 18, 2022, there were 44,973,141 shares of Puma Biotechnology common stock outstanding.

back to top
What is Puma’s CUSIP number?

The CUSIP number for Puma Biotechnology common stock is 74587V107.

back to top
Does Puma pay dividends on its common stock?

No.

back to top
Does Puma offer a Direct Stock Purchase Plan?

No.

back to top
Who serves as Puma’s stock transfer agent?

EQ Shareowner Services SM.

back to top
If I’ve lost my stock certificate or have a change of address, whom should I contact?

EQ Shareowner Services SM P.O. Box 64854 St Paul, MN 55164 Phone: (1) 800-468-9716 Website: www.shareowneronline.com

back to top
Who is Puma’s independent registered public accounting firm?

KPMG LLP

back to top
When does Puma’s fiscal year end?

December 31.

back to top
When and where will Puma’s annual meeting of stockholders be held?

The 2022 annual meeting of stockholders will be held at 1:00 p.m. PDT on June 14, 2022, at Puma's headquarters in Los Angeles.

back to top
Where are Puma’s headquarters located?

Puma’s headquarters are located at 10880 Wilshire Blvd., Suite 2150, Los Angeles, CA 90024.

back to top
How can I get copies of Puma’s financial statements or other regulatory filings?

Puma’s financial statements and other reports filed with the SEC are available on the SEC Filings page of our website at https://investor.pumabiotechnology.com/sec-filings/financials.

back to top
If I have questions regarding the company, whom should I contact?

Please contact Mariann Ohanesian, Senior Director, Investor Relations:Phone: (1) 424-248-6500, Ext. 2011 Email: ir@pumabiotechnology.com

back to top